FDA says injecting yourself with ‘young plasma’ has no benefit, so stop doing it

News
gettyimages-115577347-594x594_1550683363573_73950384_ver1.0_640_360_1550764534753.jpg

HARBURG, GERMANY – JUNE 08: A man donates blood plasma at the blood donation service Hamburg on June 8, 2011 in Harburg, Germany. Hospitals and the Red Cross in northern Germany have appealed to the public for blood donations as a result of the current outbreak of enterohemorrhagic E. coli, also known as the EHEC […]

The FDA has issued a warning after recent reports of various establishments in several states offering infusions of plasma from “young donors” that allegedly treat a variety of conditions. 

Those conditions range from normal aging and memory loss to more serious diseases like dementia, Parkinson’s disease, and Alzheimer’s. 

“There is no proven clinical benefit of infusion of plasma from young donors to cure, mitigate, treat, or prevent these conditions,” the FDA said in a statement.

Health officials say treatments using plasma from young donors have not been properly tested by the FDA to confirm “the therapeutic benefit of a product and to ensure its safety.”

“We strongly discourage consumers from pursuing this therapy outside of clinical trials under appropriate institutional review board and regulatory oversight,” the FDA added. 

Health officials say “there is no compelling clinical evidence” on the effectiveness of using plasma from young donors and there is no information on “appropriate dosing for treatment of the conditions for which these products are advertised.”

Simply put — don’t do it! 

The FDA says reports are making the rounds of “bad actors charging thousands of dollars for infusions that are unproven and not guided by evidence from adequate and well-controlled trials.”

Those looking to learn more about treatment of conditions such as dementia or Alzheimer’s are encouraged to consult their physicians. 

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

LKQD Outstream

Trending Stories

news-app-download-apple-350x50news-app-download-android-350x50